Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibiotics.

Saved in:
Bibliographic Details
Title: Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibiotics.
Authors: Robas M; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain., Presa J; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain., Arranz-Herrero J; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain.; Facultad de Medicina, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU , Madrid, Spain., Yildiz S; Department of Microbiology and Molecular Medicine, Medical Faculty, University of Geneva , Geneva, Switzerland.; Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA., Rius-Rocabert S; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain.; Facultad de Medicina, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU , Madrid, Spain.; CEMBIO (Centre for Metabolomics and Bioanalysis), Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain., Llinares-Pinel F; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain., Probanza A; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain., Schmolke M; Department of Microbiology and Molecular Medicine, Medical Faculty, University of Geneva , Geneva, Switzerland.; Geneva Center of Inflammation Research, Medical Faculty, University of Geneva , Geneva, Switzerland., Jiménez PA; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain., Nistal-Villan E; Department of Pharmaceutical and Health Sciences School of Pharmacy, Microbiology Section, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain.; CEMBIO (Centre for Metabolomics and Bioanalysis), Facultad de Farmacia, Universidad San Pablo-CEU , Madrid, Spain.
Source: Microbiology spectrum [Microbiol Spectr] 2024 Jan 11; Vol. 12 (1), pp. e0363522. Date of Electronic Publication: 2023 Dec 05.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2165-0497
DOI:10.1128/spectrum.03635-22